abacavir 600 MG Lamivudine 300 MG Oral Tablet Epzicom

1 INDICATIONS AND USAGE EPZICOM, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection. EPZICOM, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )

ViiV Healthcare Company

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] pain` `[4] off label use` `[5] nausea` `[6] headache` `[7] rash` `[8] arthralgia` `[9] diarrhoea` `[10] rheumatoid arthritis`

4 years ago

OVAL ORANGE GS FC2

16 HOW SUPPLIED/STORAGE AND HANDLING EPZICOM is available as tablets. Each tablet contains 600 mg of abacavir as abacavir sulfate and 300 mg of lamivudine. The tablets are orange, film-coated, modified capsule-shaped, and debossed with GS FC2 on one side with no markings on the reverse side. They are packaged as follows: Bottles of 30 tablets (NDC 49702-206-13). Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) (see USP Controlled Room Temperature).

More pills like OVAL GS FC2

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

abacavir 600 MG Lamivudine 300 MG Oral Tablet Epzicom

FDA Reported Adverse Reactions [1] drug ineffective [2] fatigue [3] pain [4] off label use [5] nausea [6] headache [7] rash [8] arthralgia [9] diarrhoea [10] rheumatoid arthritis

OVAL ORANGE GS FC2

More pills like OVAL GS FC2

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] pain` `[4] off label use` `[5] nausea` `[6] headache` `[7] rash` `[8] arthralgia` `[9] diarrhoea` `[10] rheumatoid arthritis`